MyChesCo on MSN1d
Arbutus Biopharma Advances Clinical Trials and Strengthens Financial Position in Q3 2024
Arbutus Biopharma Corporation (Nasdaq: ABUS) has released its third-quarter 2024 financial results, showcasing significant ...
News Medical2d
Research shows low vaccination rates for hepatitis A and B in men who have sex with men
While sex between men is the second most commonly reported route of acute hepatitis B virus infection in Europe, only three ...
Men who have sex with men in Europe still vulnerable to hepatitis A and B
Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...
Promising Potential of Arbutus Biopharma’s Imdusiran in Achieving Functional Cure for Hepatitis B: Ed Arce’s Buy Rating
Ed Arce, an analyst from H.C. Wainwright, maintained the Buy rating on Arbutus Biopharma (ABUS – Research Report). The associated price ...
EurekAlert!3d
Men who have sex with men in Europe still vulnerable to hepatitis A and B, highlighting need for public health action and support
Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...
gna3d
Ghana off track in the fight against viral hepatitis – WHO
By Muniratu Akweley Issah  Accra, Nov 06, GNA- Dr. Kafui Senya, the Technical Lead for Hepatitis at the World Health Organization (WHO) country office, has stated that ...
Eagle-Tribune4d
Immunocore reports third quarter financial results and provides a business update
GAITHERSBURG, Md., US, 06 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...
The Most Dangerous Germs Without Effective Vaccines
Researchers at the World Health Organization have identified 17 pathogens most in need of new or improved vaccines, including threats like HIV, malaria, and influenza.
gastroenterologyadvisor4d
HCV Prevalence Is Linked to Age, Drug Use Patterns in Men Who Have Sex With Men
The prevalence of HCV among men who have sex with men with non-injection drug use is linked to age and drug use patterns.
Zacks.com on MSN5d
Gilead Science to Report Q3 Earnings: What's in the Cards?
The Liver Disease portfolio sales include chronic hepatitis C virus, chronic hepatitis B virus and chronic hepatitis delta ...
Vir Biotechnology’s Promising Hepatitis Programs and Strategic FDA Alignment Justify Buy Rating
Vir Biotechnology (VIR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick ...
Targeting a specific gene could be key to treating hepatitis B, C and D
Chronic viral hepatitis is the long-term inflammation of the liver. It is caused by hepatitis B, C or D virus particles. Even ...